drugset
Drugs / ALA
last change Jun 2025 re-read 3 minutes ago

ALA

Developed for
actinic keratosis
Investigated by
Chinese Academy of Medical Sciences · First Affiliated Hospital of Kunming Medical University · General Hospital of Ningxia Medical University · Huadong Hospital · Peking University First Hospital · Shanghai Dermatology Hospital

Trials 1

today NCT03642535 · Ph 4
20192020202120222023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 4 NCT03642535 Aug 2018 → Jun 2025 actinic keratosis Shanghai Dermatology Hospital Unknown No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as ALA ClinicalTrials.gov intervention name — accepted as the source's own label NCT03642535 ↗
Route Topical “a 1-mm thick layer of 10% ALA was applied to the all face” NCT03642535 ↗